CANCER

Bloodwise 67
Report of the Trustees for the year ended 31 March 2015
Officers & advisers
SENIOR MANAGEMENT *
Catherine Gilman, Chief Executive
Professor Chris Bunce, Research Director
Jonathan Cox, Finance Director
Emma Whelan, Marketing Director
Mark Wilson, Fundraising Director
RESEARCH COMMITTEE MEMBERS*
Professor Paul Farrell (Chair), Imperial College London
Professor Christian Bastard, Centre Henri Becquerel, Rouen, France
Professor Julian Dyson, Imperial College London
Professor David Gillespie, University of Glasgow
Professor Tessa Holyoake, University of Glasgow
Dr Richard Jenner, University College London
Dr Stefan Meyer, University of Manchester
Professor Robert Slany, University of Erlangen, Germany
Dr Martin Turner, Babraham Institute, Cambridge
Professor Mark Vickers, University of Aberdeen
Dr Marieke von Lindern, Amsterdam Medical Center, Netherlands
Professor Christian Buske, University of Ulm, Germany
Dr Mary Callahan, Université Joseph Fourier, Grenoble, France
CLINICAL TRIALS COMMITTEE*
Professor Irene Roberts (Chair), University of Oxford
Dr Jamie Cavenagh, Bart’s Cancer Institute, London
Professor Christine Chomienne, Institut Universitaire
d’Hematologie, Paris, France
Professor Stephen Devereux, King’s College Hospital, London
Professor Paul Farrell, Imperial College London
Dr Claire Harrison, Guys and St. Thomas’ NHS Foundation Trust
Professor Peter Hillmen, St James’ University Hospital, Leeds
Dr Robert Hills, Cardiff University
Professor Graham Jackson, Northern Centre for Cancer Care,
Newcastle
Dr Martin Pule, University College London
Professor Simon Rule, Derriford Hospital, Plymouth
Dr Anna Schuh, University of Oxford
TRAINING & CAREER DEVELOPMENT COMMITTEE *
Professor Chris Gregory (interim chair),
University of Edinburgh
Professor Matthew Collin, Newcastle University
Professor Paul Farrell, Imperial College London
Dr Adele Fielding, University College London
Dr Reuben Tooze, University of Leeds
Professor Chris Pepper, Cardiff University
BANKERS
Barclays Bank PLC. 1 Churchill Place, London E14 5HP
AUDITOR
Deloitte LLP, Chartered Accountants & Registered Auditors
2 New Street Square, London EC4A 3BZ
INVESTMENT MANAGERS
Cazenove Capital Management Ltd with Charity Investment
from Schroders, 12 Moorgate, London EC2R 6DA
INVESTMENT ADVISER
Andrew Hutton
LEGAL ADVISERS
Fieldfisher, Riverbank House, 2 Swan Lane, London EC4R 3TT
Nabarro, Lacon House, 84 Theobald’s Road, London WC1X 8RW
REGISTRATION
Our registered name is Bloodwise.
We are registered with the Charity Commission of England and
Wales (Charity number 216032) and in Scotland (Charity number
SC037529) and as a company limited by guarantee (registered
number 738089).
PRINCIPAL OFFICE
Our registered office is 39–40 Eagle Street, London WC1R 4TH
OUR REGIONAL OFFICES
Scotland: 12–14 Hillside Crescent, Edinburgh EH7 5EA
North: Newcastle University, Biomedical Research Building,
Room 2.35, 2nd Floor Campus for Ageing and Vitality, Newcastle
upon Tyne NE4 5PL
Midlands: Medical School, University of Birmingham,
Edgbaston B15 2TT
Wales: Department of Haematology, School of Medicine, Room 182,
7th Floor, B–C Link, Cardiff University, Heath Park, Cardiff CF14 4X
South West: Unit 40, Basepoint Business Centre, Yeoford Way,
Exeter EX2 8LB
London and South East: 39–40 Eagle Street, London WC1R 4TH
Bloodwise trading as Leukaemia & Lymphoma Research Company limited by guarantee 738089
Registered charity 216032 (England & Wales) SC037529 (Scotland)